3,076 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Miracle Mile Advisors LLC

Miracle Mile Advisors LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,076 shares of the company's stock, valued at approximately $240,000.

Several other institutional investors have also recently made changes to their positions in the company. LGT Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies during the third quarter valued at $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after purchasing an additional 168 shares during the period. Institutional investors own 82.06% of the company's stock.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Price Performance

Shares of GEHC traded down $0.26 during mid-day trading on Friday, reaching $84.74. 2,854,683 shares of the company's stock were exchanged, compared to its average volume of 3,233,586. GE HealthCare Technologies Inc. has a 52-week low of $71.31 and a 52-week high of $94.55. The company has a market cap of $38.72 billion, a price-to-earnings ratio of 23.28, a PEG ratio of 2.80 and a beta of 1.11. The company has a 50-day simple moving average of $82.00 and a two-hundred day simple moving average of $84.27. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion during the quarter, compared to analysts' expectations of $4.87 billion. During the same quarter in the previous year, the business earned $0.99 EPS. The company's revenue for the quarter was up .9% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio is currently 3.30%.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their target price for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. Evercore ISI upped their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.